- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/417 - Imidazole-alkylamines, e.g. histamine, phentolamine
Patent holdings for IPC class A61K 31/417
Total number of patents in this class: 486
10-year publication summary
|
34
|
35
|
29
|
42
|
34
|
38
|
35
|
50
|
41
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SpringWorks Therapeutics, Inc. | 111 |
24 |
| Opus Genetics, Inc. | 27 |
19 |
| Allergan, Inc. | 2438 |
14 |
| Teikoku Pharma USA, Inc. | 87 |
10 |
| Ocuphire Pharma, Inc. | 35 |
9 |
| Centre National de La Recherche Scientifique | 10102 |
7 |
| Belhaven Biopharma, Inc. | 14 |
6 |
| Novartis AG | 11254 |
5 |
| Lexicon Pharmaceuticals, Inc. | 204 |
5 |
| Ltd "valenta-intellekt" | 152 |
5 |
| Universite de Montpellier | 960 |
5 |
| Jiangsu Yahong Meditech Co., Ltd. | 54 |
5 |
| VALO Health, Inc. | 168 |
5 |
| Bristol-myers Squibb Company | 4863 |
4 |
| The Regents of the University of California | 19517 |
4 |
| Bayer HealthCare LLC | 1383 |
4 |
| The Johns Hopkins University | 5533 |
4 |
| Allergan Holdings Unlimited Company | 41 |
4 |
| Tohoku University | 2683 |
4 |
| Vella Bioscience, Inc. | 29 |
4 |
| Other owners | 339 |